Alzheimer’s Drug Discovery Foundation

#Alzheimer's #Alzheimer's Drug Discovery Foundation #Biomarkers #Drug discovery #Parkinson's #Partnership #The Michael J Fox Foundation #The Michael J Fox Foundation for Parkinson’s Research (MJFF)

US$5m partnership targets Alzheimer’s and Parkinson’s biomarkers

The Alzheimer’s Drug Discovery Foundation’s (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) have announced a new US$5 million partnership to accelerate the development of minimally invasive biomarkers for measuring pathologies associated with Parkinson’s and Alzheimer’s diseases. Isobel Coleman, Chief Executive Officer of the Alzheimer’s Drug Discovery… Read More

#News